JADVALEN

Johnson & Johnson

Application Filed: 2019-08-20

Trademark Application Details

Mark For: JADVALEN™ trademark registration is intended to cover the categories of human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives. [all]

Status

2020-02-16 UTC

LIVE APPLICATION Published for Opposition

A pending trademark application has been examined by the Office and has been published in a way that provides an opportunity for the public to oppose its registration.

Research	OneLook Acronym Finder
Serial Number	88585648
Mark Literal Elements	JADVALEN
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK
Register	PRINCIPAL
Current Location	PUBLICATION AND ISSUE SECTION 2019-11-18
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Cheryl L. Foytlin
Attorney Docket Number	T45409US1
Law Office Assigned	L50
Employee Name	WILLIAMS, KRISTIN MARI

Timeline

2019-08-20	Application Filed
2019-11-18	Location: PUBLICATION AND ISSUE SECTION
2019-12-24	Published
2019-12-24	Published for Opposition
2019-12-24	Status: Application has been published for opposition. The opposition period begins on the date of publication.
2019-12-24	Status: Live/Pending
2019-12-24	Transaction Date

Trademark Parties (Applicants & Owners)

Party:	JOHNSON & JOHNSON
Address	One Johnson & Johnson Plaza New Brunswick, NEW JERSEY UNITED STATES 08933
Legal Entity Type	Corporation
Legal Entity State	NEW JERSEY

Party:	JOHNSON & JOHNSON
Address	One Johnson & Johnson Plaza New Brunswick NJ 08933
Legal Entity Type
Legal Entity State	NJ

*multiple parties listed, check assignment documents for ownership information

Documents

Drawing	IMAGE/JPEG	2019-08-20
TEAS RF New Application	MULTI	2019-08-20
Notation to File	XML	2019-11-13
TRAM Snapshot of App at Pub for Oppostn	APPLICATION/XML,IMAGE/JPEG	2019-11-14
Notice of Publication	XML	2019-12-04
Notification Of Notice of Publication	XML	2019-12-04
OG Publication Confirmation	APPLICATION/XML	2019-12-24

Attorney of Record

CHERYL L. FOYTLIN
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933

Good, Services, and Codes

IC 005. US 006 018 044 046 051 052. G & S: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Type Code

Type

GS0051

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Trademark Filing History

Description	Date	Proceeding Number
PUBLISHED FOR OPPOSITION	2019-12-24
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2019-12-24
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2019-12-04
APPROVED FOR PUB - PRINCIPAL REGISTER	2019-11-13
ASSIGNED TO EXAMINER	2019-11-08	92464
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2019-09-05
NEW APPLICATION ENTERED IN TRAM	2019-08-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.